Nexalin peer-reviewed study demonstrates brain-network effects in chronic insomnia with neuroimaging data — Psychotherapy and Psychosomatics

Summary

Nexalin Technology published a peer-reviewed study with neuroimaging data in Psychotherapy and Psychosomatics demonstrating brain-network effects and clinical improvement in chronic insomnia from their DIFS neurostimulation. The neuroimaging component — showing objective brain network changes alongside clinical symptom improvement — is the most rigorous evidence yet for Nexalin's deep-brain frequency stimulation approach, providing mechanistic fMRI/neuroimaging validation that distinguishes DIFS from placebo-like effects and positions it for payer reimbursement discussions.